Itani, Rania
Khojah, Hani MJ
Karout, Samar
Abu-Farha, Rana
Mukattash, Tareq L.
Rahme, Deema
Housary, Khouloud
Achi, Hiam El
Safar, Ali O.
Al Hajj, Ismail Karam
El-Lakany, Abdalla
Article History
Received: 14 November 2022
Accepted: 9 May 2023
First Online: 23 May 2023
Declarations
:
: The authors declare no competing interests.
: The World Medical Association Declaration of Helsinki guidance was followed in designing and conducting this study. The protocol was approved by the Institutional Review Board of Beirut Arab University (No. 2022-H-0081-P-R-0472). The purpose of the study was clearly stated to the pharmacy owners as well as the female participants. The participants had the right to defer from continuing the interview at any time. An informed consent was obtained from all the study subjects. The details related to the pharmacy or the participants’ identification were replaced by codes. Participants were not contacted afterward for any additional questioning. Moreover, the recruited interviewers are among the study authors, so no further ethical parameters were required.
: Not applicable.